Gennova Biopharmaceuticals, in partnership with CEPI, will advance the development of a self-amplifying mRNA vaccine against ...

Emcutix Biopharmaceuticals has signed an exclusive in-licensing agreement with WiQo for PRX-PLUS, a non-invasive skin tightening treatment. The deal will allow Emcutix to import, promote, and ...

Currently there are no authorized vaccines or targeted drugs against Nipah, which kills an estimated 75% of those it infects.

Gennova Biopharmaceuticals Ltd. on Tuesday announced that it is partnering with the Coalition for Epidemic Preparedness Innovations (CEPI), a subsidiary of Emcure Pharmaceuticals Ltd. for the ...

Under the partnership agreement, Emcutix Biopharmaceuticals has the right to import and sell 'PRX-PLUS', a skin-tightening ...

Emcure Pharmaceuticals shares gained 2% after its subsidiary entered into a partnership with WiQo to distribute the ...

Emcutix Biopharmaceuticals, a wholly owned subsidiary of Emcure Pharmaceuticals, announced an exclusive in-licensing agreement with WiQo, an innovative Italian derma-cosmetic and medical device ...

Pune: Emcure Pharmaceuticals Ltd. subsidiary Gennova Biopharmaceuticals Ltd., is advancing the development of a pathbreaking ...

Dr Sanjay Singh, CEO of Gennova Biopharmaceuticals, said the firm will do preclinical and phase 1 vaccine tests in India, ...

Nipah virus, a highly lethal pathogen belonging to the Paramyxovirus family, has caused multiple outbreaks in South and ...

Mumbai: Global private equity firm Bain Capital is looking to divest its stake in listed pharmaceutical manufacturer Emcure ...

Ice cream is arguably the most popular form of dessert around the world, with the young, the old, and everyone in between ...